Chapter title |
α2β1 Integrin.
|
---|---|
Chapter number | 3 |
Book title |
I Domain Integrins
|
Published in |
Advances in experimental medicine and biology, July 2014
|
DOI | 10.1007/978-94-017-9153-3_3 |
Pubmed ID | |
Book ISBNs |
978-9-40-179152-6, 978-9-40-179153-3
|
Authors |
Madamanchi A, Santoro SA, Zutter MM, Aasakiran Madamanchi, Samuel A. Santoro, Mary M. Zutter, Madamanchi, Aasakiran, Santoro, Samuel A., Zutter, Mary M. |
Abstract |
The α2β1 integrin, also known as VLA-2, GPIa-IIa, CD49b, was first identified as an extracellular matrix receptor for collagens and/or laminins [55, 56]. It is now recognized that the α2β1 integrin serves as a receptor for many matrix and nonmatrix molecules [35, 79, 128]. Extensive analyses have clearly elucidated the α2 I domain structural motifs required for ligand binding, and also defined distinct conformations that lead to inactive, partially active or highly active ligand binding [3, 37, 66, 123, 136, 137, 140]. The mechanisms by which the α2β1 integrin plays a critical role in platelet function and homeostasis have been carefully defined via in vitro and in vivo experiments [76, 104, 117, 125]. Genetic and epidemiologic studies have confirmed human physiology and disease states mediated by this receptor in immunity, cancer, and development [6, 20, 21, 32, 43, 90]. The role of the α2β1 integrin in these multiple complex biologic processes will be discussed in the chapter. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 6 | 21% |
Researcher | 4 | 14% |
Student > Ph. D. Student | 3 | 10% |
Student > Doctoral Student | 3 | 10% |
Professor | 1 | 3% |
Other | 1 | 3% |
Unknown | 11 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 5 | 17% |
Immunology and Microbiology | 4 | 14% |
Medicine and Dentistry | 2 | 7% |
Agricultural and Biological Sciences | 2 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 2 | 7% |
Unknown | 13 | 45% |